Biological and Chemical Safety Program
- NOTIFICATION OF USE (NOU) -
NOTIFICATION OF USE
for Biological and Recombinant Work
Principal Investigators are required to submit a Notification of Use (NOU) for Biological Agents, recombinant material, Human and Non-Human Primate Products for Institutional Biosafety Committee (IBC) approval prior to any work being conducted.
Addition of new agents to existing protocol is not permitted a new NOU must be submitted.
The IBC meets each first Friday of the month. All paperwork must be provided to EHS Biological and Chemical Safety (B&C) Program two weeks prior to the meeting. Contact B&C Program at (409) 772-1781 if you have any questions.
Amendment form to existing NOU:
Keck, Aerobiology and Optical Microscopy Core facilities NOU amendment form (Revised 08-12)
Section II Recombinant section (BSL2) form (Revised 03-12)
Section III Animal use (BSL2) form (Revised 03-12)
Section IV Arthropod use (BSL2) form (Revised 03-12)
Section II Recombinant section (BSL3-4 and Select Agent) form (Revised 03-12)
Section IV Animal use (BSL3-4 and Select Agent) form (Revised 03-12)
Section V Arthropod use (BSL3-4 and Select Agent) form (Revised 03-12)
Note: the recombinant section (II) might have to be resubmitted when adding animal or arthropod work to an existing NOU.
Add or delete personnel on existing NOU form
Special Immunization request form (Use for FDA approved vaccines)
Risk Assessment for Special Immunization request Form 1 and Form 2 (Use for IND/Global vaccines)